GM 32165/GM/NIGMS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1984	2
1985	3
1986	5
1987	5
1988	4
1989	6
1990	4
1991	5
1992	4
1993	7
1994	2
1995	7
1996	15
1997	5
1998	4
1999	10
2000	3
2001	2
2002	3
2003	2
2004	2
2005	1
2006	3
2007	3
2008	6
2009	3
2010	3
2011	2
2012	1
2022	0

1

Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs.

Ritchie TK, Grinkova YV, Bayburt TH, Denisov IG, Zolnerciks JK, Atkins WM, Sligar SG. Ritchie TK, et al. Methods Enzymol. 2009;464:211-31. doi: 10.1016/S0076-6879(09)64011-8. Methods Enzymol. 2009. PMID: 19903557 Free PMC article.

2

The role of transporters in drug interactions.

Endres CJ, Hsiao P, Chung FS, Unadkat JD. Endres CJ, et al. Eur J Pharm Sci. 2006 Apr;27(5):501-17. doi: 10.1016/j.ejps.2005.11.002. Epub 2005 Dec 20. Eur J Pharm Sci. 2006. PMID: 16364611 Review.

3

Metabolism of valproate to hepatotoxic intermediates.

Baillie TA. Baillie TA. Pharm Weekbl Sci. 1992 Jun 19;14(3A):122-5. doi: 10.1007/BF01962701. Pharm Weekbl Sci. 1992. PMID: 1502011 Review.

4

The complex interaction between ethanol and acetaminophen.

Slattery JT, Nelson SD, Thummel KE. Slattery JT, et al. Clin Pharmacol Ther. 1996 Sep;60(3):241-6. doi: 10.1016/S0009-9236(96)90050-8. Clin Pharmacol Ther. 1996. PMID: 8841146 Review. No abstract available.

5

Pharmacokinetics of polypharmacy: prediction of drug interactions.

Mather GG, Levy RH. Mather GG, et al. Epilepsy Res Suppl. 1996;11:113-21. Epilepsy Res Suppl. 1996. PMID: 9294732 Review. No abstract available.

6

Drug interactions at the blood-brain barrier: fact or fantasy?

Eyal S, Hsiao P, Unadkat JD. Eyal S, et al. Pharmacol Ther. 2009 Jul;123(1):80-104. doi: 10.1016/j.pharmthera.2009.03.017. Epub 2009 Apr 22. Pharmacol Ther. 2009. PMID: 19393264 Free PMC article. Review.

7

Mass spectrometry in the analysis of glutathione conjugates.

Baillie TA, Davis MR. Baillie TA, et al. Biol Mass Spectrom. 1993 Jun;22(6):319-25. doi: 10.1002/bms.1200220602. Biol Mass Spectrom. 1993. PMID: 8329460 Review. No abstract available.

8

Inhibition-based metabolic drug-drug interactions: predictions from in vitro data.

Yao C, Levy RH. Yao C, et al. J Pharm Sci. 2002 Sep;91(9):1923-35. doi: 10.1002/jps.10179. J Pharm Sci. 2002. PMID: 12210040 Review.

9

Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid.

Baillie TA. Baillie TA. Chem Res Toxicol. 1988 Jul-Aug;1(4):195-9. doi: 10.1021/tx00004a001. Chem Res Toxicol. 1988. PMID: 2979731 Review. No abstract available.

10

A quantitative index of substrate promiscuity.

Nath A, Atkins WM. Nath A, et al. Biochemistry. 2008 Jan 8;47(1):157-66. doi: 10.1021/bi701448p. Epub 2007 Dec 15. Biochemistry. 2008. PMID: 18081310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results